An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Bio-Rad’s Chief Operating Officer Andrew Last to Retire
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Bio-Rad Laboratories, Inc. announces the retirement of Dr. Andrew Last, the Executive Vice President and COO, by early September 2024. Dr. Last, with over 30 years of experience, joined in 2019 and played a vital role in the company's transformational objectives and navigating macroeconomic challenges. The company is conducting a search for his successor.
Positive
None.
Negative
None.
HERCULES, Calif.--(BUSINESS WIRE)--
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that Dr. Andrew Last, Executive Vice President and Chief Operating Officer, is planning to retire by early September of 2024. Dr. Last will remain part of Bio-Rad’s executive leadership team to ensure a smooth transition while the company conducts a search for his successor.
Dr. Last joined Bio-Rad in April of 2019 with over 30 years of experience in global operations management spanning the life sciences.
“Andy’s extensive operations experience, technical acumen, and leadership abilities have been invaluable to Bio-Rad over the past five years,” said Norman Schwartz, Bio-Rad President and CEO. “We have made significant progress on our transformational objectives, including cost structure, core processes, and supply chain improvements, while effectively navigating various macroeconomic challenges.”
Dr. Last stated, “When I reflect on my tenure at Bio-Rad, I am most proud of the team we have built and the operations and management systems we have put in place. I am confident that these accomplishments have positioned Bio-Rad well for the next phase of its continued journey of transformation and growth.”
About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) is a leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets. Based in Hercules, California, Bio-Rad operates a global network of research, development, manufacturing, and sales operations with over 8,000 employees and $2.7 billion in revenues in 2023. Our customers include universities, research institutions, hospitals, food safety and environmental quality laboratories, and biopharmaceutical companies. Together, we develop innovative, high-quality products that advance science and save lives. To learn more, visit bio-rad.com.
Investor Contact:
Edward Chung, Investor Relations
510-741-6104
ir@bio-rad.com
Media Contact:
Anna Gralinska, Corporate Communications
510-741-6643
cc@bio-rad.com
Source: Bio-Rad Laboratories, Inc.
FAQ
When is Dr. Andrew Last planning to retire from Bio-Rad Laboratories, Inc.?
Dr. Andrew Last, the Executive Vice President and COO, is planning to retire by early September 2024.
How long has Dr. Andrew Last been with Bio-Rad Laboratories, Inc.?
Dr. Andrew Last joined Bio-Rad in April of 2019 with over 30 years of experience in global operations management.
Who will ensure a smooth transition after Dr. Andrew Last's retirement?
Dr. Andrew Last will remain part of Bio-Rad’s executive leadership team to ensure a smooth transition while the company conducts a search for his successor.
What progress has Bio-Rad Laboratories, Inc. made under Dr. Andrew Last's leadership?
Bio-Rad has made significant progress on transformational objectives, including cost structure, core processes, and supply chain improvements, while navigating various macroeconomic challenges.
What did Dr. Andrew Last mention about his tenure at Bio-Rad Laboratories, Inc.?
Dr. Last stated that he is most proud of the team they have built and the operations and management systems put in place, positioning Bio-Rad well for the next phase of transformation and growth.
